Lipid disorders in patients with renal failure: Role in cardiovascular events and progression of chronic kidney disease-Reference-Cited by-同舟云学术

Lipid disorders in patients with renal failure: Role in cardiovascular events and progression of chronic kidney disease

Published:2016-12 Issue: Volume:6 Page:8-14
ISSN:2214-6237
Container-title:Journal of Clinical & Translational Endocrinology
language:en
Short-container-title:Journal of Clinical & Translational Endocrinology

Author:

Visconti Luca,Benvenga Salvatore,Lacquaniti Antonio,Cernaro Valeria,Bruzzese Annamaria,Conti Giovanni,Buemi Michele,Santoro Domenico

Publisher

Elsevier BV

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Reference73 articles.

1. Alterations of lipid metabolism in chronic nephropathies: mechanisms, diagnosis and treatment;Lacquaniti;Kidney Blood Press Res,2010

2. A historical perspective on the discovery of statins;Endo;Proc Jpn Acad Ser B Phys Biol Sci,2010

3. Prediction of coronary heart disease using risk factor categories;Wilson;Circulation,1998

4. Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356,222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT);Stamler;JAMA,1986

5. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S);Lancet,1994

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lipoprotein-associated phospholipase A2 predicts cardiovascular death in patients on maintenance hemodialysis: a 7-year prospective cohort study;Lipids in Health and Disease;2024-01-12

2. Left Ventricular Mass Index Predicts Renal Function Decline in Patients with Chronic Kidney Disease;Medicina;2024-01-10

3. Dietary fatty acids intake and all-cause and cardiovascular mortality in patients on peritoneal dialysis;Clinical Nutrition;2023-11

4. Dyslipidemia in Patients with Chronic Kidney Disease: An Updated Overview;Diabetes & Metabolism Journal;2023-09-30

5. Correlation of Stromelysin-1 and Tissue Inhibitor of Metalloproteinase-1 with Lipid Profile and Atherogenic Indices in End-Stage Renal Disease Patients: A Neural Network Study;Pertanika Journal of Science and Technology;2023-06-13